PPARG and fatty liver disease: Changes similar to the inhibition of hepatic steatosis were observed in the mRNA expressions of four adipogenesis and lipogenesis related genes (PPARγ, C/EBPα, FAS, and aP2) in the HFD + Vehicle- and HFD + LEP-treated groups.